Please provide your email address to receive an email when new articles are posted on . Men who have depression before prostate cancer diagnosis may have significantly greater risk for death than ...

One in every 8 men in the United States will develop prostate cancer, according to prostate cancer statistics released by the American Cancer Society. In the US, advanced prostate cancer diagnoses ...

Montell Jordan, who rose to fame with his 1995 hit song, “This Is How We Do It,” revealed exclusively on the 3rd Hour of TODAY that his prostate cancer has returned. “I always imagined I would be ...

In a new report from the American Cancer Society, mortality rates for prostate cancer are two times higher for Black men compared to White men. A new report from the American Cancer Society (ACS) ...

Montell Jordan, the son of South L.A. who shot to fame in 1995 with the hit “This Is How We Do It,” says his prostate cancer has returned despite having a radical prostatectomy last year. “We thought ...

September is officially Prostate Cancer Awareness Month across the country and in the Capital City.Jackson Mayor John Horhn made the official declaration Tuesday morning. He was joined with other ...

The steepest increases were seen for advanced-stage disease. Prostate cancer rates have risen in recent years, with a sharp increase in cases diagnosed in advanced stages, the American Cancer Society ...

Changes in screening recommendations over a decade ago may have inadvertently resulted in later diagnosis of the most common cancer in men, a new study has found. By Roni Caryn Rabin Prostate cancer ...

During National Prostate Cancer Awareness Month, we send our unwavering support to the millions of American men and families who have faced prostate cancer with courage and resolve. We recognize those ...

Immunohistochemical Analysis of Androgen Receptor Expression Predicts the Prognosis of Metastatic Castration-Sensitive Prostate Cancer Patients Receiving Abiraterone Acetate. February 4, 2025 The ...

Editor's note: The Larger Trend section has been updated. California-based Artera, a company that develops multimodal AI-based prognostic and predictive cancer tests, has been granted de novo ...

ArteraAI Prostate is now an FDA-regulated software (as a medical device) to estimate long-term outcomes and predict the benefit of hormone therapy for individual patients with localized prostate ...